Skip to main content
. 2021 Jul 19;12:691878. doi: 10.3389/fphar.2021.691878

FIGURE 3.

FIGURE 3

Forest plot of the effect of canagliflozin on the composite of cardiovascular death, cardiovascular mortality, heart failure, Myocardial infaction and stroke of the T2DM participants.